JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function

Journal: Science Translational Medicine

Published: 2020-02-12

DOI: 10.1126/scitranslmed.aay4447

Affiliations: 4

Authors: 15

Go to article
Institutions Share
Department of Medicine 3 - Rheumatology and Immunology, FAU, Germany 0.48
Deutsches Zentrum Immuntherapie (DZI), FAU, Germany 0.48
Nikolaus Fiebiger Center of Molecular Medicine (NFZ), FAU, Germany 0.02
University Hospital of Erlangen, FAU, Germany 0.02